Info
Clinical Setting of Neutropenia-Febrile-High-Risk
- Febrile neutropenia: Post-cancer chemotherapy or post-allogeneic bone marrow transplant patient with fever (≥38.3°C x 1 hr of sustained over 38°C) AND neutropenic (absolute neutrophil count range from <500-<1000 cells/μL)
- High risk: Inpatient status at time of development of fever, significant medical comorbidity or clinically unstable, anticipated neutropenia of ≤100 cells/μL and ≥ 7 days, hepatic or renal insufficiency, uncontrolled/progressive cancer, pneumonia or other complex infections, mucositis grade 3-4, MASCC Risk Index score of < 21, Alemtuzumab.